162 related articles for article (PubMed ID: 35694516)
1. Wide-Line NMR Melting Diagrams, Their Thermodynamic Interpretation, and Secondary Structure Predictions for A30P and E46K α-Synuclein.
Bokor M; Házy E; Tantos Á
ACS Omega; 2022 Jun; 7(22):18323-18330. PubMed ID: 35694516
[TBL] [Abstract][Full Text] [Related]
2. Missense Mutations Modify the Conformational Ensemble of the
Guzzo A; Delarue P; Rojas A; Nicolaï A; Maisuradze GG; Senet P
Front Mol Biosci; 2021; 8():786123. PubMed ID: 34912851
[No Abstract] [Full Text] [Related]
3. Wild-Type
Guzzo A; Delarue P; Rojas A; Nicolaï A; Maisuradze GG; Senet P
Front Mol Biosci; 2022; 9():910104. PubMed ID: 35836937
[No Abstract] [Full Text] [Related]
4. Structures of the E46K mutant-type α-synuclein protein and impact of E46K mutation on the structures of the wild-type α-synuclein protein.
Wise-Scira O; Dunn A; Aloglu AK; Sakallioglu IT; Coskuner O
ACS Chem Neurosci; 2013 Mar; 4(3):498-508. PubMed ID: 23374074
[TBL] [Abstract][Full Text] [Related]
5. Phase transitions and structure analysis in wild-type, A30P, E46K, and A53T mutants of α-synuclein.
Healey MA; Woodside MT; Tuszynski JA
Eur Biophys J; 2016 May; 45(4):355-64. PubMed ID: 26695014
[TBL] [Abstract][Full Text] [Related]
6. Distinct residual and disordered structures of alpha-synuclein analyzed by amide-proton exchange and NMR signal intensity.
Okuwaki R; Shinmura I; Morita S; Matsugami A; Hayashi F; Goto Y; Nishimura C
Biochim Biophys Acta Proteins Proteom; 2020 Sep; 1868(9):140464. PubMed ID: 32497661
[TBL] [Abstract][Full Text] [Related]
7. Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.
Kumar S; Sarkar A; Sundar D
Biochem Biophys Res Commun; 2009 Sep; 387(2):305-9. PubMed ID: 19580781
[TBL] [Abstract][Full Text] [Related]
8. WT and A53T α-Synuclein Systems: Melting Diagram and Its New Interpretation.
Bokor M; Tantos Á; Tompa P; Han KH; Tompa K
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503167
[TBL] [Abstract][Full Text] [Related]
9. E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease.
Sakai R; Suzuki M; Ueyama M; Takeuchi T; Minakawa EN; Hayakawa H; Baba K; Mochizuki H; Nagai Y
PLoS One; 2019; 14(6):e0218261. PubMed ID: 31242217
[TBL] [Abstract][Full Text] [Related]
10. Structures and free energy landscapes of the wild-type and A30P mutant-type α-synuclein proteins with dynamics.
Wise-Scira O; Aloglu AK; Dunn A; Sakallioglu IT; Coskuner O
ACS Chem Neurosci; 2013 Mar; 4(3):486-97. PubMed ID: 23374072
[TBL] [Abstract][Full Text] [Related]
11. Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.
Bodner CR; Maltsev AS; Dobson CM; Bax A
Biochemistry; 2010 Feb; 49(5):862-71. PubMed ID: 20041693
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein-induced tubule formation in lipid bilayers.
Pandey AP; Haque F; Rochet JC; Hovis JS
J Phys Chem B; 2011 May; 115(19):5886-93. PubMed ID: 21520980
[TBL] [Abstract][Full Text] [Related]
13. Distinct hydration properties of wild-type and familial point mutant A53T of α-synuclein associated with Parkinson's disease.
Hazy E; Bokor M; Kalmar L; Gelencser A; Kamasa P; Han KH; Tompa K; Tompa P
Biophys J; 2011 Nov; 101(9):2260-6. PubMed ID: 22067166
[TBL] [Abstract][Full Text] [Related]
14. Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements.
Ruf VC; Nübling GS; Willikens S; Shi S; Schmidt F; Levin J; Bötzel K; Kamp F; Giese A
ACS Chem Neurosci; 2019 Mar; 10(3):1649-1659. PubMed ID: 30605594
[TBL] [Abstract][Full Text] [Related]
15. Label-free detection of early oligomerization of α-synuclein and its mutants A30P/E46K through solid-state nanopores.
Li X; Tong X; Lu W; Yu D; Diao J; Zhao Q
Nanoscale; 2019 Mar; 11(13):6480-6488. PubMed ID: 30892349
[TBL] [Abstract][Full Text] [Related]
16. Change in the Oligomeric State of α-Synuclein Variants in Living Cells.
Fan HF; Chen WL; Chen YZ; Huang JW; Shen YX
ACS Chem Neurosci; 2022 Apr; 13(8):1143-1164. PubMed ID: 35394271
[TBL] [Abstract][Full Text] [Related]
17. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martínez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; Liao D
J Neurosci; 2018 Nov; 38(45):9754-9767. PubMed ID: 30249789
[TBL] [Abstract][Full Text] [Related]
18. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.
Choi W; Zibaee S; Jakes R; Serpell LC; Davletov B; Crowther RA; Goedert M
FEBS Lett; 2004 Oct; 576(3):363-8. PubMed ID: 15498564
[TBL] [Abstract][Full Text] [Related]
19. Structures and free energy landscapes of the A53T mutant-type α-synuclein protein and impact of A53T mutation on the structures of the wild-type α-synuclein protein with dynamics.
Coskuner O; Wise-Scira O
ACS Chem Neurosci; 2013 Jul; 4(7):1101-13. PubMed ID: 23607785
[TBL] [Abstract][Full Text] [Related]
20. Familial Parkinson disease mutations influence α-synuclein assembly.
Ono K; Ikeda T; Takasaki J; Yamada M
Neurobiol Dis; 2011 Sep; 43(3):715-24. PubMed ID: 21684335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
